Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders.
STAT4 controls GM-CSF production by both Th1 and Th17 cells during EAE.
JC virus-iLOV fluorescent strains enable the detection of early and late viral protein expression.
Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
Genetic burden in multiple sclerosis families.
Synergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosis.
Effect of treadmill training on fatigue in multiple sclerosis: a pilot study.
Risperidone-Induced Pisa Syndrome in MS: Resolution with Lurasidone and Recurrence with Chlorpromazine.
Protective Autoimmunity: A Unifying Model for the Immune Network Involved in CNS Repair.
Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis.
Biopsy Proven Tumefactive Multiple Sclerosis with Concomitant Glioma: Case Report and Review of the Literature.
Multicontrast MRI Quantification of Focal Inflammation and Degeneration in Multiple Sclerosis.
Optimizing treatment initiation: Effects of a patient education program about fingolimod treatment on knowledge, self-efficacy and patient satisfaction.
Role of microRNAs in the regulation of innate immune cells under neuroinflammatory conditions.
Sequential activation of microglia and astrocyte cytokine expression precedes increased iba-1 or GFAP immunoreactivity following systemic immune challenge.
Why this is not multiple sclerosis: a case based approach.
Multiple Sclerosis and Risk of Infection-Related Hospitalization and Death in US Veterans.
Rates of Adverse Events and Multiple Sclerosis Relapses Before and After Introduction of a Purported Generic Glatiramer Acetate in mexico: Results from a Large Patient Support Program in Mexico.
mTORC1 signaling and IL-17 expression: Defining pathways and possible therapeutic targets.
Monoclonal Antibodies for Multiple Sclerosis Treatment.
X-linked Charcot-Marie-Tooth disease type 6 (CMTX6) patients with a p.R158H mutation in the pyruvate dehydrogenase kinase isoenzyme 3 gene.
The TIM-3 pathway ameliorates Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Multiple sclerosis update.
Insights into multiple sclerosis provided by non-coding RNAs: meeting summary from the symposium 'Non-coding RNAs in autoimmune disorders of the central nervous system' on 5 April 2013 in Warsaw, Poland.
Biomarker time out.

Pages